These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4811085)

  • 1. One-year contraception with norgestrienone subdermal silastic implants.
    Coutinho EM; da Silva AR
    Fertil Steril; 1974 Feb; 25(2):170-6. PubMed ID: 4811085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Egg-laying factor in the hen: 17 alpha-ethylyltrenolone].
    Grandadam JA; Klein G; Dreux H; Deroy R; Bonnemain F; Pottier J; Busigny M
    Ann Nutr Aliment; 1973; 27(3):163-80. PubMed ID: 4766921
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of reproduction and of undesirable social and sexual behaviour in dogs and cats.
    Gerber HA; Jöchle W; Sulman FG
    J Small Anim Pract; 1973 Mar; 14(3):151-8. PubMed ID: 4738952
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of an oral progestin contraceptive, R-2323, 5mg, administered at weekly intervals.
    Mora G; Faundes A; Pastore U
    Contraception; 1974 Aug; 10(2):145-57. PubMed ID: 4421020
    [No Abstract]   [Full Text] [Related]  

  • 5. Contraceptive effectiveness of Silastic implants containing the progestin R-2323.
    Coutinho EM; Da Silva AR; Carreira CM; Chaves MC; Adeodato Filho J
    Contraception; 1975 Jun; 11(6):625-35. PubMed ID: 1137935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dosage oral progestogens to control fertility. I. clinical investigation.
    Zanartu J; Dabancens A; Oberti C; Rodriquez-Bravo R; Garcia-Huidobro M
    Obstet Gynecol; 1974 Jan; 43(1):87-96. PubMed ID: 4587643
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial with subdermal implants of the progestin R-2323.
    Diaz S; Pavez M; Quniteros E; Robertson DN; Croxatto HB
    Contraception; 1977 Aug; 16(2):155-65. PubMed ID: 913113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical chemistry in women treated with progestogen implants.
    Croxatto HB; Diaz S; Pavez M
    Contraception; 1978 Oct; 18(4):441-50. PubMed ID: 720076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prolonged progestational and anti-estrogenic activity of 6,11beta-dichloro-3beta, 17-dihydroxy-19-nor-4,6-pregnadien-20-one 17-acetate 3beta-benzoate (gr2/2132).
    Gilbert HG; Woollett EA; Child KJ
    Steroids; 1974 Nov; 24(5):731-6. PubMed ID: 4476097
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of an anabolic steroid (Norbolethone) on the function of the isolated perfused rat liver.
    Bassan H; Kendler J; Harinasuta U; Zimmerman HJ
    Biochem Pharmacol; 1971 Jul; 20(7):1429-35. PubMed ID: 5163083
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with implant contraception.
    Coutinho E
    Contraception; 1978 Oct; 18(4):411-27. PubMed ID: 720074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facts about an implantable contraceptive: memorandum from a WHO meeting.
    Bull World Health Organ; 1985; 63(3):485-94. PubMed ID: 3930082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eighteen months contraception following subdermal insertion of silastic capsules containing norgestrienone.
    Da Silva AR; Coutinho EM
    Int J Fertil; 1978; 23(3):185-92. PubMed ID: 40892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach to estrogen-free contraception based on progesterone receptor blockage by mid-cycle administration of ethyl norgestrienone (R 2323).
    Sakiz E; Azadian-Boulanger G; Laraque F; Raynaud JP
    Contraception; 1974 Nov; 10(5):467-74. PubMed ID: 4375015
    [No Abstract]   [Full Text] [Related]  

  • 15. The biological profile of a new synthetic progestagen--GR2-1159-(17-acetoxy-6,11 beta-dichloro-19-nor-4,6-pregnadiene-3,20-dione).
    Child KJ; English AF; Gilbert HG; Woollett EA
    Steroids; 1974 Mar; 23(3):425-42. PubMed ID: 4133334
    [No Abstract]   [Full Text] [Related]  

  • 16. Contraceptive steroid administration by subdermal implants: serum concentrations of R-2323, estrogen and progesterone in rhesus monkeys.
    Bahgat MR; Atkinson LE
    Contraception; 1977 Mar; 15(3):335-45. PubMed ID: 880812
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trial with subdermal implants containing norgestrienone.
    Diaz S; Pavez M; Quinteros E; Diaz J; Robertson DN; Croxatto HB
    Contraception; 1978 Oct; 18(4):429-40. PubMed ID: 720075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The remote changes in the endometrial histology and the cervicovaginal cytology with the long acting hormonal contraceptive.
    Sammour MB; El-Hafiz MA
    Fertil Steril; 1970 Jun; 21(6):464-8. PubMed ID: 4927704
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of clomiphene, cyclofenil, epimestrol and Ro 4-8347 on pituitary and serum prolactin in mature female rats.
    Maeda HR; Seki M; Seki K; Yoshihara T
    Endocrinol Jpn; 1972 Dec; 19(6):525-32. PubMed ID: 4679231
    [No Abstract]   [Full Text] [Related]  

  • 20. PROGESTATIONAL ACTIVITY OF A NEW ACETOXYPROGESTERONE DERIVATIVE (6 ALPHA-METHYL-6-DEHYDRO-17 ALPHA-ACETOXYPROGESTERONE).
    GREENBLATT RB; JUNGCK EC; BIGGER JT; GREER MV
    Fertil Steril; 1963; 14():393-401. PubMed ID: 14060305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.